Geode Capital Management, LLC Travere Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,003,701 shares of TVTX stock, worth $34.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,003,701

Previous 1,976,661 1.37%

Holding current value

$34.9 Million

Previous $35.4 Million 16.28%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$13.49 - $21.54 $364,769 - $582,441	27,040 Added 1.37%	2,003,701 $29.7 Million
Q1 2025 May 13, 2025	BUY	$17.07 - $23.75 $2.29 Million - $3.19 Million	134,360 Added 7.29%	1,976,661 $35.4 Million
Q4 2024 Feb 12, 2025	BUY	$13.65 - $19.85 $1.52 Million - $2.21 Million	111,256 Added 6.43%	1,842,301 $32.1 Million
Q3 2024 Nov 12, 2024	BUY	$7.89 - $15.21 $510,830 - $984,756	64,744 Added 3.89%	1,731,045 $24.2 Million
Q2 2024 Aug 09, 2024	BUY	$5.26 - $8.28 $554,472 - $872,819	105,413 Added 6.75%	1,666,301 $13.7 Million
Q1 2024 May 13, 2024	BUY	$7.18 - $9.82 $281,154 - $384,531	39,158 Added 2.57%	1,560,888 $12 Million
Q4 2023 Feb 13, 2024	BUY	$5.44 - $9.5 $441,107 - $770,317	81,086 Added 5.63%	1,521,730 $13.7 Million
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $373,504 - $843,318	48,888 Added 3.51%	1,440,644 $12.9 Million
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $2.68 Million - $3.96 Million	175,182 Added 14.4%	1,391,756 $21.4 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $2.13 Million - $2.74 Million	119,563 Added 10.9%	1,216,574 $27.4 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $676,094 - $956,854	36,605 Added 3.45%	1,097,011 $23.1 Million
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $812,869 - $1.02 Million	35,481 Added 3.46%	1,060,406 $26.1 Million
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $711,478 - $1.02 Million	-33,977 Reduced 3.21%	1,024,925 $24.8 Million
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $368,764 - $477,941	15,619 Added 1.5%	1,058,902 $27.3 Million
Q4 2021 Feb 11, 2022	BUY	$24.34 - $31.17 $1.44 Million - $1.85 Million	59,305 Added 6.03%	1,043,283 $32.4 Million
Q3 2021 Nov 12, 2021	SELL	$12.98 - $25.03 $278,563 - $537,168	-21,461 Reduced 2.13%	983,978 $23.9 Million
Q2 2021 Aug 13, 2021	BUY	$14.11 - $26.4 $680,003 - $1.27 Million	48,193 Added 5.03%	1,005,439 $14.7 Million
Q1 2021 May 12, 2021	BUY	$23.37 - $31.77 $4.66 Million - $6.33 Million	199,385 Added 26.31%	957,246 $23.9 Million
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $14.5 Million - $21.1 Million	757,861 New	757,861 $20.7 Million

Others Institutions Holding TVTX

# of Institutions

231

Shares Held

102M

Call Options Held

1.73M

Put Options Held

401K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Travere Therapeutics, Inc. Transaction History